UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050524
Receipt number R000057536
Scientific Title The effects of Lee Silverman Voice Treatment (LSVT) BIG on cognitive functions among people with Parkinson's disease
Date of disclosure of the study information 2023/03/07
Last modified on 2025/03/08 09:21:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of Lee Silverman Voice Treatment (LSVT) BIG on cognitive functions among people with Parkinson's disease

Acronym

The effects of Lee Silverman Voice Treatment (LSVT) BIG on cognitive functions among people with Parkinson's disease

Scientific Title

The effects of Lee Silverman Voice Treatment (LSVT) BIG on cognitive functions among people with Parkinson's disease

Scientific Title:Acronym

The effects of Lee Silverman Voice Treatment (LSVT) BIG on cognitive functions among people with Parkinson's disease

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to reveal the effects of LSVT BIG on cognitive functions among people with Parkinson's disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Mini mental state examination
The Japanese version of Montreal cognitive assessment
frontal assessment battery

Key secondary outcomes


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

people with Parkinson's disease who were admitted to Kakeyu Hospital

Key exclusion criteria

people with other neurological diseases
medication adjustment during LSVT BIG
requests of deregistration from individuals with Parkinson's disease or their family
people who fail to complete LSVT BIG

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Keita
Middle name
Last name Sue

Organization

JA Nagano Kouseiren Kakeyu Misayama Rehabilitation center Kakeyu Hospital

Division name

Department of Rehabilitation

Zip code

386-0396

Address

1308, Kakeyuonsen, Ueda, Nagano, Japan

TEL

0268-44-2111

Email

keitasue@live.jp


Public contact

Name of contact person

1st name Keita
Middle name
Last name Sue

Organization

JA Nagano Kouseiren Kakeyu Misayama Rehabilitation center Kakeyu Hospital

Division name

Department of Rehabilitation

Zip code

386-0396

Address

1308, Kakeyuonsen, Ueda, Nagano, Japan

TEL

0268-44-2111

Homepage URL


Email

keitasue@live.jp


Sponsor or person

Institute

Keita Sue
Department of Rehabilitation, Kakeyu Misayama Rehabilitation center Kakeyu Hospital

Institute

Department

Personal name



Funding Source

Organization

Keita Sue
Department of Rehabilitation, Kakeyu Misayama Rehabilitation center Kakeyu Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

JA Nagano Kouseiren Kakeyu Misayama Rehabilitation center Kakeyu Hospital

Address

1308, Kakeyuonsen, Ueda, Nagano, Japan

Tel

0268-44-2111

Email

keitasue@live.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

JA長野厚生連鹿教湯三才山リハビリテーションセンター鹿教湯病院(長野県)


Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 10 Month 01 Day

Date of IRB

2022 Year 10 Month 15 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2027 Year 11 Month 01 Day

Date of closure to data entry

2027 Year 11 Month 01 Day

Date trial data considered complete

2027 Year 11 Month 01 Day

Date analysis concluded

2029 Year 11 Month 01 Day


Other

Other related information

In group comparison of cognitive tests between before and after LSVT BIG.
To determine what factor influences the improvement of cognitive function.


Management information

Registered date

2023 Year 03 Month 07 Day

Last modified on

2025 Year 03 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057536